Abstract:Pediatric acute myeloid leukemia (pAML) encompasses over 20 molecular subtypes driven by unique genetic alterations, including hallmark chromosomal rearrangements and less frequently, point mutations or tandem duplications. Collectively, many of these pAML molecular categories are enriched in pediatric populations and are not represented by current classification systems, including the recently updated WHO or ICC. While fusion detection from RNA-Seq-based approaches is robust, many fusion negative subtypes would need to be defined by expression-based approaches as mutation calling from RNA-Seq data is less developed. Nevertheless, this could be challenging for subtypes with similar transcriptional profiles, such as those with shared HOX expression patterns, including NPM1, NUP98r, UBTF, DEK::NUP214, and KMT2A-PTD. To aid in the appropriate molecular classification of pAML, which is crucial for prognosis, we developed and compared three gene expression-based classifiers. A total of 1707 pAML gene expression profiles were mapped and analyzed from three distinct sources (St. Jude = 659; TARGET = 168; AAML1031 = 880). Raw read count data was normalized and scaled to obtain a relative expression value in transcripts per million (TPM), which served as input for feature selection, model training, and testing. Ground truth labels for all 1707 samples were obtained through multi-omics analysis, including whole genome sequencing, to identify fusions and mutations. For validation purposes, the data was stratified by subtypes and split 70/30 into training (n=1187) and testing (n=520). Three machine learning models were selected: random forest, XGboost, and linear support vector machine (SVM). Each sample had gene expression TPM data for 60,754 transcripts, out of which 20,004 transcripts related to protein-coding genes were incorporated for feature selection. Feature selection was performed using a median absolute deviation (MAD) algorithm to select the 3000 transcripts with the highest variability. Top variable 3000 genes were selected to allow for adequate tuning of the number of predictors. Each model was independently trained using stratified cross-validation and Monte-Carlo search for hyperparameter tuning. The best model was selected based on the Matthews Correlation Coefficient (MCC). Each model was tested on the hold-out TPM set with z-score normalization. On the hold-out testing set (n=520), the linear SVM model outperformed the random forest and XGboost models on five performance metrics across all subtypes (sensitivity=0.9577; precision=0.9577; specificity=0.9978; F1=0.96; accuracy=0.9958). The random forest (sensitivity=0.9154; precision=0.9154; specificity=0.9955; F1=0.92; accuracy=0.9915) and XGboost models (sensitivity=0.9231; precision=0.9231; specificity=0.9960; F1=0.92; accuracy=0.9923) also performed well across all subtypes. Although feature selection was shared across all three models, performance within each subtype varied between models. The linear SVM model demonstrated strong performance overall, driven by high specificity in classifying the KMT2Ar subgroup (n=127) and equal sensitivity across the GLIS-rearranged (n=14), GATA1 (n=10), BCL11B (n=7), CBFB::MYH11 (n=60), CEBPA (n=33), and RUNX1::RUNX1T1 (n=78) subtypes. The primary difference in performance between models is the high false positive rate for KMT2Ar and NPM1 (n=55) in the random forest and XGboost models. A preliminary hypothesis for this might be due to the large representation of KMT2Ar and NPM1 in the training data (24.85% and 10.78%, respectively). Synthetic upsampling (SMOTE) for the training dataset (n=1369) counteracts bias towards the majority classes and increases performance for the random forest (sensitivity=0.9327; precision=0.9327; specificity=0.9965; F1=0.93; accuracy=0.9933), XGboost (sensitivity=0.9404; precision=0.9404; specificity=0.9969; F1=0.94; accuracy=0.9940) and linear SVM (sensitivity=0.9615; precision=0.9615; specificity=0.9980; F1=0.96; accuracy=0.9962) models. Conjointly, these models demonstrate the utility and effectiveness of a machine learning approach for classifying pAML samples from transcriptome sequencing data, which may have broad clinical and research utility, especially for fusion negative subtypes.

Machine learning based on multiplatform tests assists in subtype classification of mature B‐cell neoplasms

Machine learning models-based on integration of next-generation sequencing testing and tumor cell sizes improve subtype classification of mature B-cell neoplasms

The Molecular Prognostic Scoring System for Normal Karyotype Myelodysplastic Syndromes

Development and Validation of Deep Learning Model for Diagnosis and Subtypes Differentiation of Myeloproliferative Neoplasms Using Clinical Data and Digital Pathology

Machine Learning and Deep Learning CT-Based Models for Predicting the Primary Central Nervous System Lymphoma and Glioma Types: A Multicenter Retrospective Study

Gene Expression Machine Learning Models Classify Pediatric AML Subtypes with High Performance

Combinatory strategy using nanoscale proteomics and machine learning for T cell subtyping in peripheral blood of single multiple myeloma patients

Development and validation of a deep learning model for morphological assessment of myeloproliferative neoplasms using clinical data and digital pathology

Advancing NSCLC pathological subtype prediction with interpretable machine learning: a comprehensive radiomics-based approach

Molecular subtypes predict therapeutic responses and identifying and validating diagnostic signatures based on machine learning in chronic myeloid leukemia

Classification of multiple primary lung cancer in patients with multifocal lung cancer: assessment of a machine learning approach using multidimensional genomic data

Differentiating Between Multiple Myeloma and Metastasis Subtypes of Lumbar Vertebra Lesions Using Machine Learning–Based Radiomics

Value of genomics- and radiomics-based machine learning models in the identification of breast cancer molecular subtypes: a systematic review and meta-analysis

Radiomic‐Based MRI for Classification of Solitary Brain Metastases Subtypes From Primary Lymphoma of the Central Nervous System

NGS panel enhance precise diagnosis of myeloid neoplasms under WHO-HAEM5 and International Consensus Classification: An observational study

Predicting Molecular Alterations from Blast Morphology of Acute Myeloid Leukemia Bone Marrow Aspirate Smears Using Machine Learning

Molecular Classification Models for Triple Negative Breast Cancer Subtype Using Machine Learning

Development and Validation of Machine Learning–based Model for the Prediction of Malignancy in Multiple Pulmonary Nodules: Analysis from Multicentric Cohorts

Classification of acute myeloid leukemia M1 and M2 subtypes using machine learning

Genomic Landscape and Molecular Subtypes of Primary Central Nervous System Lymphoma

Transcriptome-based molecular subtypes and differentiation hierarchies improve the classification framework of acute myeloid leukemia